Acuamark Diagnostics
PrivateLast Round
Series A
Extension
Jun 4, 2024
Total Funding Raised
$17.72M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Acuamark Diagnostics is a molecular diagnostics company developing blood-based screening technology for the early detection of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acuamark Diagnostics Comparables
Compare Acuamark Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Harbinger Health | 87% | |
| Adela | 84% | |
| EarlyDiagnostics | 83% |
Acuamark Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 4, 2024 | ||||
| Series A | Jul 19, 2022 | ||||
| Private Placement | Dec 27, 2019 | ||||
| VC Round | Sep 25, 2019 | ||||
| Seed | Nov 17, 2016 |
Acuamark Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| XLerateHealth | Accelerator |
| Harvard Business School Alumni Angels of Greater New York | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 234% MoM, reaching 2K.
- Jul 19, 2022
$11.3M round led by Bruker.
Acuamark Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Acuamark Diagnostics's valuation, stock price, and market status.
Is Acuamark Diagnostics a public or private company?
Acuamark Diagnostics is a private company.
What is the current stock price of Acuamark Diagnostics?
Acuamark Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is Acuamark Diagnostics worth (valuation)?
Valuation information for Acuamark Diagnostics is not publicly available.
Can I buy Acuamark Diagnostics stock?
Acuamark Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Acuamark Diagnostics's last funding round?
Acuamark Diagnostics's most recent funding round was Series A Extension on June 4, 2024.
Who are the main investors in Acuamark Diagnostics?
Key investors in Acuamark Diagnostics include Harvard Business School Alumni Angels of Greater New York.
Will Acuamark Diagnostics IPO soon?
No public IPO plans have been announced for Acuamark Diagnostics.
How can I track Acuamark Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Acuamark Diagnostics's secondary market activity and sign up for updates.